| Literature DB >> 22491789 |
Krishna K Varadhan1, Keith R Neal, Dileep N Lobo.
Abstract
OBJECTIVE: To compare the safety and efficacy of antibiotic treatment versus appendicectomy for the primary treatment of uncomplicated acute appendicitis.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22491789 PMCID: PMC3320713 DOI: 10.1136/bmj.e2156
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Definitions of outcome measures
| Outcome measure | Antibiotic treatment | Appendicectomy |
|---|---|---|
| Complications | Perforated/gangrenous appendicitis or peritonitis and wound infection (in patients who failed antibiotic treatment and had appendicectomy subsequently) | Perforated appendicitis or peritonitis and wound infection |
| Length of primary hospital stay | Number of days of inpatient admission for patients who were treated with antibiotics following admission and discharged with oral antibiotics | Number of days of inpatient admission for patients who had appendicectomy and were discharged with further follow-up |
| Readmissions | Patients who were readmitted for operations or antibiotic related problems, such as diarrhoea, and including wound infections after surgery for failed antibiotic treatment; also those who were readmitted for recurrent symptoms | Patients who were readmitted with postoperative complications such as intra-abdominal collections, adhesive obstruction, or wound infections |
| Treatment efficacy | Patients who were successfully treated with antibiotics only and had none of the following: failure of antibiotic treatment or recurrence of symptoms needing appendicectomy; development of any post-therapeutic or postoperative complications | Patients who were successfully treated with appendicectomy and had none of the following: no appendicitis on histology; development of any post-therapeutic or postoperative complications including readmissions |

Fig 1 PRISMA flow diagram

Fig 2 Treatment outcome: antibiotics

Fig 3 Treatment outcome: appendicectomy
Summary of outcomes
| Study | No of patients | Age (years) | Successful treatment with intervention | Complications | Recurrences | Mean (SD) length of stay (days) | Diagnoses in patients who had appendicectomy | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | S | A | S | A | S | A | S | A | S | A | S | Antibiotics | Surgery | |||||||
| Vons 201124 | 120 | 119 | Mean 34 (SD 12) | Mean 38 (SD 13) | 81 | 119 | 3 | 12 | 30 | 0 | 3.96 (4.87) | 3.04 (1.5) | 44 had appendicectomy: 14 within 30 days (9 complicated, 4 uncomplicated, 1 normal); 30 between 30 days and 1 year (3 complicated, 23 uncomplicated, 4 normal) | Appendicectomy: 119 (21 complicated appendicitis, 98 uncomplicated appendicitis) | ||||||
| Hansson 200920 | 202 | 167 | Mean 38 (SEM 1) | Mean 38 (SEM 1) | 83 | 142 | 51 | 55 | 15 | 0 | 3 (0.1) | 3 (0.2) | 119 patients had antibiotics and 83 others crossed over to surgery; appendicectomy: 21 (out of 119); 9 appendicitis in primary admission: 3 phlegmonous; 3 gangrenous, 3 perforated. (1 normal appendix, 1 surgically treatable); 12/15 recurrences had appendicectomy: 8 phlegmonous, 1 gangrenous, 3 perforated (3 treated with antibiotics) | 83 crossed over to surgery from antibiotics (evaluated per protocol); appendicectomy: 250; 220 (128 phlegmonous, 42 gangrenous, 50 perforated); other diagnoses: 30 (3 other surgically treatable causes, 14 surgically non-treatable, and 13 normal) | ||||||
| Styrud 200626 | 128 | 124 | Range 18-50; mean not reported | Range: 18-50; mean not reported | 97 | 120 | 4 | 17 | 16 | 0 | 3.0 (1.4) | 2.6 (1.2) | Appendicectomy:31 (15 primary, 16 readmissions); 1 primary had terminal ileitis; 12 perforated; 18 phlegmonous | Appendicitis: 120 (6 perforated, 1 gangrenous, 3 mesenteric adenitis, 1 no pathology) | ||||||
| Eriksson 199527 | 20 | 20 | Mean 27 (range 18-53) | Mean 35 (range 19-75) | 13 | 17 | 0 | 2 | 7 | 0 | 3.1 (0.3) | 3.4 (1.9) | Appendicectomy: 8 (1 primary, 7 readmissions); 6 phlegmonous and 1 perforated | Appendicitis 17 (8 phlegmonous, 8 gangrenous, 1 perforated); 3 normal | ||||||
| Total | 470 | 430 | 274 | 398 | 58 | 86 | 68 | 0 | 98/104 | 357/394 | ||||||||||
A=antibiotics; S=surgery.

Fig 4 Antibiotic treatment versus appendicectomy for uncomplicated appendicitis: forest plot for complications

Fig 5 Antibiotic therapy versus appendicectomy for uncomplicated appendicitis: forest plot for length of primary hospital stay

Fig 6 Antibiotic therapy versus appendicectomy for uncomplicated appendicitis: forest plot for risk of complicated appendicitis
GRADE Analysis: antibiotics versus appendicectomy for uncomplicated acute appendicitis—quality assessment
| Critical outcome | Participants (studies); follow-up | Risk of bias* | Inconsistency* | Indirectness | Imprecision | Publication bias | Overall quality of evidence† |
|---|---|---|---|---|---|---|---|
| Complications: | |||||||
| All studies | 900 (4 studies); 1 year | Seriousa,b,c | Seriousa,d | No | No | Undetected | +/+/−/−; low due to risk of bias and inconsistency |
| Studies with no crossover of patients | 531 (3 studies); 1 year | Seriousd | No serious inconsistency | No | No | Undetected | +/+/+/−; moderate due to risk of bias |
| Length of primary hospital stay: | |||||||
| All studies | 900 (4 studies); 1 year | Seriousa,b,c | Seriousa | No | No | Undetected | +/+/−/−; low due to risk of bias and inconsistency |
| Studies with no crossover of patients | 531 (3 studies); 1 year | Seriousd | No serious inconsistencyd | No | No | Undetected | +/+/+/−; moderate due to risk of bias |
| Risk of complicated appendicitis: | |||||||
| All studies | 896 (4 studies); 1 year | Seriousa,b,d | Seriousa | No | No | Undetected | +/+/−/−; low due to risk of bias and inconsistency |
| Studies with no crossover of patients | 527 (3 studies); 1 year | Seriousd | Seriouse | No | No | Undetected | +/+/−/−; low due to risk of bias and inconsistency |
*Basis for assumed risk: a) incomplete accounting of patients and events; b) randomisation by date of birth; c) crossover of patients after randomisation; d) excluded female patients; e) definitions of outcome vary between trials.
†GRADE Working Group grades of evidence: high quality—further research very unlikely to change confidence in estimate of effect; moderate quality—further research likely to have important impact on confidence in estimate of effect and may change estimate; low quality—further research very likely to have important impact on confidence in estimate of effect and likely to change estimate; very low quality—very uncertain about estimate.
GRADE Analysis: antibiotics versus appendicectomy for uncomplicated acute appendicitis—summary of findings
| Critical outcome | Study event rates (%) | Relative effect (95% CI) | Anticipated absolute effects | ||
|---|---|---|---|---|---|
| With control | With antibiotics | Risk with control | Risk difference with antibiotics* (95% CI) | ||
| Complications: | |||||
| All studies | 108/430 (25) | 84/470 (18) | 0.69 (0.54 to 0.89) | Study population | |
| 251 per 1000 | 78 (28 to 116) fewer per 1000 | ||||
| Moderate† | |||||
| 194 per 1000 | 60 (21 to 89) per 1000 | ||||
| Studies with no crossover of patients | 50/263 (19) | 31/268 (12) | 0.61 (0.4 to 0.92) | Study population | |
| 190 per 1000 | 74 (15 to 114) fewer per 1000 | ||||
| Moderate† | |||||
| 186 per 1000 | 73 (15 to 112) fewer per 1000 | ||||
| Length of primary hospital stay: | |||||
| All studies | 430 | 470 | 0.2 higher (0.16 lower to 0.56 higher) | ||
| Studies with no crossover of patients | 263 | 268 | 0.34 higher (0.19 lower to 0.87 higher) | ||
| Risk of complicated appendicitis: | |||||
| All studies | 129/509 (25) | 54/387 (14) | 0.68 (0.38 to 1.21) | Study population | |
| 253 per 1000 | 81 fewer (157 fewer to 53 more) per 1000 | ||||
| Moderate† | |||||
| 272 per 1000 | 87 fewer (169 fewer to 57 more) per 1000 | ||||
| Studies with no crossover of patients | 37/259 (14) | 25/268 (9) | 0.61 (0.2 to 1.89) | Study population | |
| 143 per 1000 | 56 fewer (114 fewer to 127 more) per 1000 | ||||
| Moderate† | |||||
| 177 per 1000 | 69 fewer (142 fewer to 158 more) per 1000 | ||||
*Based on assumed risk in comparison group and relative effect of intervention.
†Strength of evidence.